Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.964 USD | -2.53% | -16.78% | -36.23% |
Business Summary
Number of employees: 219
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 18 | 100.0 % | 1 | 100.0 % | -96.17% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 18 | 100.0 % | 1 | 100.0 % | -96.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Mark Frattini
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-07-31 |
Stephan Reynier
CMP | Compliance Officer | 55 | 11-03-31 |
Chief Tech/Sci/R&D Officer | 61 | 00-12-31 | |
Human Resources Officer | 54 | 20-11-15 | |
Steve Doares
PRN | Corporate Officer/Principal | - | 20-07-20 |
General Counsel | 42 | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
Laurent Arthaud
BRD | Director/Board Member | 61 | 11-10-27 |
Pierre Bastid
BRD | Director/Board Member | 69 | 11-10-27 |
Director/Board Member | 57 | 22-06-27 | |
Donald Bergstrom
BRD | Director/Board Member | 52 | 22-06-27 |
Rainer Boehm
BRD | Director/Board Member | 63 | 17-06-28 |
Cécile Chartier
BRD | Director/Board Member | - | 23-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,810,231 | 71,751,201 ( 99.92 %) | 0 | 99.92 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CALYXTPAR 2.22% | 479,264 | 2.22% | 6,930,157 $ |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.14% | 51.51B | |
-7.43% | 39.03B | |
+35.88% | 38.91B | |
-10.62% | 26.68B | |
+11.63% | 26.13B | |
-17.77% | 19.91B | |
+40.52% | 13.71B | |
+30.70% | 12.38B | |
-3.41% | 11.74B |
- Stock Market
- Equities
- ALCLS Stock
- CLLS Stock
- Company Cellectis S.A.